Abstract-DN-2327, 2-(7-chloro-1,8-naphthyridin-2-yl)-3-[(1,4-dioxa-8-azaspiro [4.5] dec-8-yl)carbonylmethyl]isoindolin-1-one, produced anxiolytic, taming and anti-convulsive effects when administered orally to several species of animals . DN-2327 produced few of the sedative-hypnotic and muscle-relaxant effects observed with diazepam.
The durations of the anxiolytic and anti-convulsive activities of DN-2327 were much longer than those of diazepam.
Tolerance to DN-2327 did not develop when it was administered daily for 14 days in an anti conflict test (Vogel conflict test).
DN-2327 showed potent displacement activity against[ 3H]diazepam binding.
The binding affinity of DN-2327 for benzodiazepine receptors was about twenty times that of diazepam.
Furthermore , the affinity of DN-2327 for benzodiazepine receptors was not enhanced by the presence of GABA . There is a wide margin between the doses of DN-2327 that cause the anxiolytic effects and its sedative-hypnotic/muscle-relaxant effects.
These results suggest that DN-2327 has more marked anxioselective properties compared with the benzodiazepines.
The benzodiazepines are the most widely prescribed of the anti-anxiety drugs for the treatment of neurotic patients. However, they have sedative-hypnotic and muscle-relaxant activities in addition to their anxiolytic action, and these side effects limit their utility, especially in geriatric patients. Furthermore, these drugs significantly potentiate the seda tive properties of other CNS depressants (1, 2) . In addition, problems involving a tendency for drug dependence (3) Materials and Methods I. Anxiolytic activity (1) Vogel conflict test 1) Potency: Male rats (Jcl:Wistar, 140 160 g) were used. The experimental pro cedures used were similar to those described by Vogel et al. (6) . Rats were deprived of water for 48 hr before the test. After the first 24 hr of water deprivation, the rat was placed in the test box and given water ad libitum without any electric shock for 30 sec. The test box (light compartment: 34 x 25 x 25 cm, dark compartment: 10x 10x 10 cm) was enclosed in a sound-proof box and equipped with a grid floor of stainless steel and a drinking bottle containing water. After another 24 hr of water deprivation, the rat was again placed in the test box. Test agents were ad ministered orally 1 hr before the test. Upon placement into the test box, each animal was allowed to drink water and to complete 20 licks or 2 sec of licking before the application of an electric shock (1.5 mA, 2 sec). During the subsequent 3-min test period, shocks were delivered every 20th lick. The number of shocks tolerated during a 3-min period was recorded.
2) Duration of action: The duration of action was studied using the same procedure as described above except that the test agents were administered 3, 6, 12, 16 and 24 hr before the test.
3) Repeated administration: DN-2327 was given orally once a day for 14 days to in vestigate changes in its anxiolytic activity related to chronic administration. The test was conducted 1 hr after the drug had been administered on the 1 4th day. (2) Geller conflict test
The procedure used was based on that described by Geller and Seifter (7). Male rats (Jcl:Wistar, 30-48 weeks old, 242-266 g) were used. They were partially deprived of food in order to maintain their body weight at 80% of the initial body weight. The rats were trained in an operant chamber to lever-press for a food reward (9% powdered milk solution with 1 % sugar added) on a multiple variable interval of 30 sec/continuous reinforcement (V130/CRF) schedule. The two schedule components were alternated during 60-min sessions. Each session began with a 12-min VI period followed by a 3-min CRF period signaled by a tone as a cue, in which every response was reinforced with food but ac companied by an electric shock (0.2-0.4 mA). This period is referred to as the "conflict period". The rats were given a food reward on a V130 schedule in the safety period without an electric shock. The control values for the conflict and safety periods were estimated after administration of saline before the drug administration studies. II. Anti-hyperemotionality (1) Anti-fighting effect in mice
The procedure employed was essentially the same as that described by Tedeschi et al. (8) . Pairs of male mice (Jcl:ICR, 5 weeks old) were selected at random and placed under an inverted 2-liter glass beaker on a grid-floor composed of stainless steel rods. A foot shock of 2 mA (AC) in intensity was de livered for 3 min from a power supply through a scrambler. The frequency of fighting epi sodes during the 3-min period was deter mined, and pairs exhibiting 5 or more fighting episodes were used for the drug tests. One or two days after the selection, 6 pairs for each dose level were given the test compound orally, and were then subjected to one 3-min fighting test 30 min later. Since all pairs showed 5 or more fighting episodes in the control test, occurrence of 4 or fewer fighting episodes after administration of the drug was regarded as a significant drug effect. The anti fighting ED50 value was calculated as the dose that significantly suppressed the fighting behavior in half of the pairs. (2) Anti-hyperemotionality in rats with septal lesions Rats with septal lesions (Jcl:Wistar, male, 9 weeks old, 250-300 g) were prepared using the procedure described elsewhere (9) . The degree of hyperemotionality before and after intraperitoneal injection of the test agent was scored according to the method of King and Meyer (10) . Reduction in the score after ad ministration of a drug was expressed as the percentage decrease compared.with the pre drug score. ED50 values were calculated as the dose that suppressed the score by 20% or more in half of the animals tested. (3) Anti-muricidal effect in rats with olfac tory bulbectomy Male rats (Jcl:Wistar, 9 weeks old, 250 300 g) were anesthetized with pentobarbital. The top of the skull was removed, and the exposed bilateral olfactory bulbs were ablated by aspiration. The muricidal response of rats thus treated was evaluated by the procedure described by Nakajima et al. (9) . The rats were assigned to groups of 6, and each animal was presented with a mouse for 10 min before and at 0.5,1,1.5 and 2 hr after drug administration. ED50 values were calculated as the dose that suppressed the muricidal response in half of the rats tested. Each rat was used several times, but only tested once a week. I 11. Taming effect in monkeys and beagle dogs (1) Cynomolgus monkeys Eight consistently hostile cynomolgus monkeys (male, 4.5-7 kg) were used. Three animals were used for each dose level. The same animals were used several times for drug testing, but at two-week intervals. The behavior of animals was rated according to a check-list devised by Norton (11) with some modifications, before and at 0.5, 1, 2, 4, 6 and 24 hr after oral administration of the test agent. In this study, the taming, sleep-inducing and muscle-relaxant effects of DN-2327 were compared with those of diazepam. (2) Beagle dogs Three male beagle dogs that showed anxious and timid behavior when confronted with the observer were used repeatedly for each dose level, but at 2-week intervals, for the drug test. The behavior of the animals was rated according to a scoring sheet devised by ourselves (Table 1) , before and at 0.5, 1, 2, 3, 5, 7 and 24 hr after oral administration of the test drug. A control experiment in which glucose was administered was carried out on the same animals before administration of the test drug. IV. Anti-convulsive effect (1) Pentylenetetrazol-induced convulsion Groups of 6 rats (Jcl:Wistar, male, 6 weeks old, 130-161 g) pretreated with the test agent were injected with 150 mg/kg, s.c. of pentylenetetrazol-HCI. The ED50 values of the test agents were evaluated as the dose that prevented death in 50% of the rats during 60 min after the pentylenetetrazol challenge. The test agents were administered orally 1 hr before the pentylenetetrazol challenge. Ad ditionally, in order to study the duration of action of the test agents, the pretreatment time was varied using periods of 0.5, 1, 2, 4, 6, 16 and 24 hr. (2) Bicuculline-induced convulsion Groups of 6 rats (Jcl:Wistar, male, 6 weeks old, 133-181 g) pretreated with the test agent were injected subcutaneously with 3 mg/kg of bicuculline. The ED50 values of the test agents were evaluated as the dose that pre vented death in 50% of the rats during 60 min after the bicuculline challenge. The test agents were given orally 1 hr before the bicuculline challenge. (3) Maximum electroshock induced convul sion Maximum electroshock seizure (MES) was produced essentially as described by Swin yard et al. (12) . Mice (Jcl:ICR, male, 4 weeks old) were challenged with a supramaximal electroshock (75 mA, 0.2 sec) delivered through bilateral corneal electrodes 30 min after administration of the test agent either orally or intraperitoneally. The ED50 value was calculated as the dose that prevented death in half of the mice. Eight mice were used per dose. V. Muscle relaxation (1) Rota-rod test Rats (Jcl:Wistar, male, 6-7 weeks old, 127-2.50 g) previously trained to remain on a rota-rod 3.5 cm in diameter (8 revolutions/ min) for more than 1 min were used. The animals were subjected to this test at 15 or 30-min intervals after administration of the test agent either orally or intraperitoneally; the ED50 value of the test agent was deter mined as the dose that caused 50% of the rats to fall off the rota-rod within 1 min. Six rats were used per dose level.
(2) Inclined screen test Male mice (Jcl:ICR, 4 weeks old, 22-25 g) were placed on a 60° inclined screen (a tetron-gauze covered plate) before and at 0.25, 0.5, 1, 1.5 and 2 hr after oral administra tion of the test agent. The ED50 value of each test agent was determined as the dose that caused 50% of the mice to slide off the screen within 1 min. Ten mice were used per dose. VI. Effect on CNS depressants (1) Pentobarbital potentiation A non-hypnotic dose of pentobarbital Na (25 mg/kg) was given intraperitoneally to groups of 8 mice (Jcl:ICR, male, 4 weeks old, 21-24.5 g) 30 min after oral administration of the test agent at various doses. Thereafter, the number of mice that showed loss of the righting reflex for more than 3 min within 30 min of receiving the pentobarbital were counted, and the ED50 value of the test agent was taken as the dose producing hypnosis in half of the mice. (2) Ethanol anesthesia potentiation Twenty-five percent ethanol was given intraperitoneally at 0.2 ml/10 g body weight 30 min after oral administration of the test agent at various doses to groups of 8 or 10 mice (Jcl:ICR, male, 4 weeks old, 23-26.5 g).
Loss of the righting reflex for a period of more than twice as long as the mean anesthetic duration in a saline-treated group was con sidered to be significant potentiation of ethanol anesthesia by the test agent. The ED50 value was calculated as the dose producing potentiation of ethanol anesthesia in 50% of the mice. The effect of DN-2327 on the inhibition of [3H]diazepam binding, as described above, was studied in the presence or absence of 100 ,uM GABA. In this study, non-specific binding was estimated in the presence of 10 PM diazepam. X. Drugs
The following drugs were used: DN-2327, 2-(7-chloro-1,8-naphthyridin-2-yl) -3 [(1,4 dioxa 8 azaspiro [4.5] dec 8 yl)carbonyl methyl]isoindolin-1 -one (Fig. 1) (14) . (Fig. 2) . The anxiolytic activity of DN-2327 was equipotent to that of diazepam at the minimum effective dose (10 mg/kg, p.o.) of each drug.
2) Duration of action: As shown in Table 2 , the duration of action of DN-2327 in this test was at least 12 hr (at 20 mg/kg, p.o.), whereas diazepam administered at 10 and 20 mg/kg, p.o., 3 and 6 hr before the test had no anti-conflict activity.
3 (Table 3) . (2) Anti-hyperemotionality in rats with sep ta) lesions
As shown in Table 3 , the ED50 values of DN-2327 and diazepam for hyperemotionality in rats with septal lesions were 7.6 mg/kg and 2.8 mg/kg, i.p., respectively. (3) Anti-muricidal effect in rats with olfac tory bulbectomy
The ED50 values of DN-2327 and dia zepam required to suppress muricidal behavior in rats with olfactory bulbectomy were 99.1 mg/kg and 16.6 mg/kg, i.p., respectively (Table 3) . Lines with solid circles represent the response rate (% of control) in the safety period. The drugs were administered 30 min before the test. *P<0.05, **P<0.01, compared with the saline control (paired t-test).
Each group was comprised of 12-14 rats.
III. Taming effect in monkeys and beagle dogs (1) Cynomolgus monkeys DN-2327 dose-dependently decreased the scores for excitement, defensive and aggres sive behavior. These effects were observed 30 min to 1 hr after drug administration and continued for about 6 hr, although they were not observed 24 hr after administration. Unlike diazepam, DN-2327 (5 and 20 mg/kg, p.o.) did not cause drowsiness nor sleep inducing and muscle-relaxant effects (Fig. 4) . (2) Beagle dogs DN-2327, at 5 and 20 mg/kg, p.o., pro duced very friendly behavior from 1 hr after drug administration. The peak effect of DN 2327 occurred at 90 min to 2 hr; and thereafter, the effect declined gradually, but continued for at least 7 hr after drug ad ministration. Twenty-four hours later, the animals had returned to their previous anxious and timid state. Neither sleep-inducing nor ataxic effects were observed during a 7-hr period after drug administration (Fig. 5) . IV. Anti-convulsive effect (1) Anti-pentylenetetrazol convulsion 1) Potency: As shown in Table 3 , DN-2327 dose-dependently suppressed the number of animal deaths induced by pentylenetetrazol challenge. The ED50 values for DN-2327 and diazepam were 0.95 and 6.1 mg/kg, p.o., respectively (pretreatment time: 1 hr and 0.5 hr, respectively).
2) Duration of action: DN-2327 showed a peak effect when given 1 hr before pentylene tetrazol administration. Its action lasted longer than that of diazepam (Table 2) . (2) Bicuculline-induced convulsion DN-2327 and diazepam dose-dependently suppressed the number of rat deaths induced by bicuculline. The ED50 values for DN-2327 and diazepam were 6.5 and 6.4 mg/kg, p.o., respectively (Table 3) . an ethanol-potentiating effect at low doses; the ED50 value was 0.11 mg/kg, p.o. VII. Spontaneous motor activity DN-2327, 10 and 40 mg/kg, p.o., did not produce any significant decrease in spon taneous motor activity counts. On the other hand, diazepam at 10 mg/kg, p.o. or more caused a significant decrease in spontaneous motor activity counts during the first 30 min and the first 60 min following diazepam ad ministration, respectively (Table 3) . VIII. Effect on body temperature DN-2327 (10, 20 and 40 mg/kg, p.o.) did not produce hypothermia during a 4-hr period after its administration.
Also, intraperitoneal injection of DN-2327 at 10 and 20 mg/kg produced no hypothermia.
Diazepam (1.25, 2.5 and 5 mg/kg, p.o.) caused dose-depen dent hypothermia. A significant change was observed at 2.5 mg/kg or more (Table 3) . IX. Neurochemical study (1) Affinity for benzodiazepine receptors in rat brain DN-2327 showed a potent affinity for the benzodiazepine receptors in rat brain; its affinity (IC50: 0.38±0.08 nM, n=5) was ap proximately 20 times that of diazepam (IC50: 8.6±2.7 nM, n=5, Table 3 ). (2) GABA ratio
The GABA ratio of DN-2327 was 1.1 ±0.1 (n=5), whereas that of diazepam was 3.0±0.7 (n=5, Table 3 ). 
Discussion
The anti-convulsive potency of DN-2327 against bicuculline-induced convulsions was as much as that of diazepam. By contrast, DN 2327 was more potent and longer lasting than diazepam in its ability to protect against the effects of pentylenetetrazol. CGS9896 (17) and suriclone (18) have been reported to possess good separation ratios between their anxiolytic and muscle-relaxant actions, and it has also been shown that these two com pounds have a more potent protective effect against pentylenetetrazol-induced convulsion than against bicuculline or picrotoxin induced convulsion. In the neurochemical study, DN-2327 showed a more potent af finity for benzodiazepine receptors than did diazepam. However, DN-2327, like CGS 9896 (19) , did not alter the GABA ratio. Thus, the degree of interaction with the GABAergic system may be a critical factor in separating the anxiolytic action of a drug from its sedative or muscle-relaxant action. These results sug gest that the pharmacologic activities of DN 2327 may be mediated via a subpopulation or a specific conformation of the benzodiazepine receptors which are not susceptible to modulation by GABA.
Wood et al. (19) reported that the non sedating benzodiazepine agonist/antagonist CGS9896 had a GABA ratio of 1 (24) exert an agonistic action on one class of benzodiazepine receptors and an antagonistic action on another class. It has been suggested that these compounds have affinities for the benzodiazepine receptors of the cerebellum that are different from those for the cerebral cortex receptors and that they have good separation ratios between their anxiolytic action and side effects. However, it is difficult to explain the relation between the pharmacologic effects and the sites of binding of CL21 8872 (21) , as this compound showed a higher affinity for the benzodiazepine receptors in the cerebellum than those in other regions of the brain, but had reduced muscle-relaxant action. Also, it is presently unclear whether the modes of CGS9896 binding differ between the cerebellum and forebrain. There is a possibility that DN-2327 may have different modes of binding for benzodiazepine receptors in various regions of the brain, since the agent has anxioselec tive properties with less marked sedative and muscle-relaxant effects. The anti -hyperemotional ity, anti-aggres siveness, anti-fighting and anti-muricidal ac tions of DN-2327 were less potent than those of diazepam. However, the dose of diazepam required to produce these actions was higher than that for its anxiolytic effect. These effects of diazepam may be considered to depend partly on its muscle-relaxant or sedative effect. In cynomolgus monkeys, DN-2327 reduced aggressiveness, excitement and defensive behavior with no motor incoordination or drowsiness and sleep induction. Furthermore, DN-2327 produced very friendly behavior in beagle dogs that had previously shown anxious and timid behavior, without pro ducing motor incoordination or drowsiness and sleep induction. With regard to spon taneous motor activity and body temperature, DN-2327 did not produce the significant changes observed with diazepam. This lack of CNS-depressant effect of DN-2327 would appear to be beneficial for medication. The number of lever-pressings in the non-punish ment period of the Geller conflict test was in creased by smaller doses of diazepam, which may be related to the disinhibitory action of this drug (25) .
In conclusion, DN-2327, a new non benzodiazepine highly selective anxiolytic drug with a novel pharmacologic profile, holds promise for the treatment of anxiety without producing sedation and muscle-relaxation as side effects. Further investigations to elucidate the mechanism of action of DN-2327 are currently in progress.
